Lamisil Spray, 1%, 15 ml

Antifungal drug for external use, which has a broad spectrum of antifungal activity. In low concentrations terbinafine has fungicidal effect against dermatophytes (Trychophyton rubrum, Trychophyton mentagrophytes, Trychophyton verrucosum, Trychophyton violaceum, Trychophyton tonsurans, Microsporum canis, Epidermophyton floccosum), molds (mainly Candida albicans) and some dimorphic fungi (Pityrosporum orbiculare).

Indications

Prevention and treatment of fungal skin infections: mycosis of the feet (tinea pedis); keratinization, cracks, itching and flaking of the skin caused by foot fungus; inguinal athlete’s foot (tinea craris), fungal infections of the smooth skin of the body (tinea corporis) caused by dermatophytes such as Trichophyton (including T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum; yeast infections of the skin, mainly those caused by fungi of the genus Candida (for example, Candida albicans), in particular diaper rash; pityriasis versicolor (Pityriasis versicolor), caused by Pityrosporum orbiculare (Malassezia furfur).

Pharmacological effect

An antifungal drug for external use with a wide spectrum of antifungal activity. In small concentrations, terbinafine has a fungicidal effect against dermatophytes (Trychophyton rubrum, Trychophyton mentagrophytes, Trychophyton verrucosum, Trychophyton violaceum, Trychophyton tonsurans, Microsporum canis, Epidermophyton floccosum), molds (mainly Candida albicans) and some dimorphic fungi (Pityrosporum orbiculare).

Special instructions

A decrease in the severity of clinical manifestations is usually observed in the first days of treatment. In case of irregular use or premature cessation, there is a risk of recurrence of infection.

The drug is intended for external use only.

Avoid contact of the drug with the eyes, because it may cause irritation. In case of accidental contact with the eyes, rinse immediately with running water, and in case of persistent irritation, consult a doctor.

If allergic reactions develop, the drug must be discontinued.

Lamisil® cream for external use contains cetyl and stearyl alcohols, which can cause local allergic reactions (contact dermatitis) at the sites of application.

Caution should be exercised when applying Lamisil® spray to damaged areas of the skin, as… the ethanol contained in it may cause irritation. Lamisil® Spray is for external use only. Lamisil® spray should not be used on the face.

Active ingredient

Terbinafine

Composition

1 g of spray contains:

Active substance:

10 mg terbinafine hydrochloride;

Excipients:

macrogol cetostearyl ether,

ethanol,

purified water,

propylene glycol,

nitrogen.

Pregnancy

Because clinical experience with Lamisil® Cream in pregnant women is very limited, it should not be used unless absolutely necessary. During pregnancy, the drug is used only if the expected benefit to the mother outweighs the potential risk to the fetus. You should consult your doctor.

In experimental studies, the teratogenic properties of terbinafine were not identified. To date, no malformations have been reported with the use of Lamisil®.

Terbinafine is excreted in breast milk, so the drug should not be prescribed to nursing mothers. The infant should not be allowed to come into contact with any skin surface treated with Lamisil®.

Contraindications

Hypersensitivity to terbinafine or to any of the inactive ingredients included in the drug; breastfeeding period; children under 18 years of age.

The drug is prescribed with caution to patients with liver and/or renal failure, patients with chronic alcoholism, suppression of bone marrow hematopoiesis, tumors, metabolic diseases, occlusive diseases of the vessels of the extremities.

Side Effects

Determination of the frequency of side effects (WHO): very common (≥1/10), common (≥1/100 and <1/10), uncommon (≥1/1000 and <1/100), rare (≥1/10,000 and <1/1000), very rare (<1/10,000), including individual reports.From the immune system: isolated reports – hypersensitivity reactions (rash).On the part of the organ of vision: rarely – eye irritation.From the skin: often – peeling of the skin, itching; uncommon – skin damage, crust formation, skin lesions, pigmentation disorders, erythema, burning sensation of the skin; rarely – a feeling of dry skin, contact dermatitis, eczema; individual messages – rash.Local reactions: uncommon – pain, pain at the site of application, irritation at the site of application; rarely – exacerbation of symptoms of the disease. In areas where the drug is applied, itching, peeling of the skin, pain, irritation, changes in skin pigmentation, burning, erythema, and crusts may occur. These minor symptoms should be distinguished from hypersensitivity reactions, such as rash, which occur in rare cases and require discontinuation of therapy. In rare cases, the course of a fungal infection may worsen.If any of these side effects worsen, or the patient notices any other side effects, the doctor should be informed.

Interaction

Currently, drug interactions with Lamisil® are unknown.

Overdose

No cases of overdose of Lamisil® have been reported.

Symptoms: Accidental ingestion of 30 ml of Lamisil® spray containing 300 mg of terbinafine hydrochloride is comparable to taking 1 tablet of Lamisil® with a dosage of 250 mg (single dose for an adult).

Clinical pharmacology

When applied topically, absorption is less than 5% and has little systemic effect.

Short product description

Lamisil® Spray is used to treat foot fungus, body fungus, pityriasis versicolor, skin candidiasis.*

Lamisil Spray is convenient to apply to areas affected by fungus. There is no need to touch infected areas, so your hands remain clean after treatment.

The active substance of the spray Lamisil terbinafine has a fungicidal effect, with which it fights the infection that causes fungus (mycosis) of the foot.*
* Instructions for medical use, RU No P N016003/02 dated 12/22/2009

Storage conditions

At a temperature not exceeding 30 °C (do not freeze)

Shelf life

3 years

Manufacturer

FreiCare Swiss AG, Switzerland